Enterprise Value
-5.916M
Cash
72.33M
Avg Qtr Burn
-22.37M
Short % of Float
2.56%
Insider Ownership
2.66%
Institutional Own.
52.87%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
AVR-RD-02 Details Gaucher disease | Phase 2/3 Initiation | |
AVR-RD-04 Details Cystinosis | Phase 2 Update | |
AVR-RD-05 Details Mucopolysaccharidoses, Mucopolysaccharidosis type II, Rare diseases, Rare genetic disease, Genetic disorder | Phase 1/2 Data readout | |
AVR-RD-01 Details Genetic disorder, Fabry disease | Failed Discontinued |